Premature ovarian failure

被引:247
作者
Beck-Peccoz, Paolo [1 ]
Persani, Luca [2 ]
机构
[1] Univ Milan, IRCCS, Fdn Osped Maggiore Policlin Mangiagalli & Regina, Dipartimento Sci Med, I-20122 Milan, Italy
[2] Univ Milan, Dipartimento Sci Med, IRCCS, Ist Auxol Italiano, I-20095 Milan, Italy
关键词
D O I
10.1186/1750-1172-1-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Premature ovarian failure (POF) is a primary ovarian defect characterized by absent menarche (primary amenorrhea) or premature depletion of ovarian follicles before the age of 40 years (secondary amenorrhea). It is a heterogeneous disorder affecting approximately 1% of women < 40 years, 1: 10,000 women by age 20 and 1: 1,000 women by age 30. The most severe forms present with absent pubertal development and primary amenorrhea (50% of these cases due to ovarian dysgenesis), whereas forms with post-pubertal onset are characterized by disappearance of menstrual cycles ( secondary amenorrhea) associated with premature follicular depletion. As in the case of physiological menopause, POF presents by typical manifestations of climacterium: infertility associated with palpitations, heat intolerance, flushes, anxiety, depression, fatigue. POF is biochemically characterized by low levels of gonadal hormones (estrogens and inhibins) and high levels of gonadotropins (LH and FSH) (hypergonadotropic amenorrhea). Beyond infertility, hormone defects may cause severe neurological, metabolic or cardiovascular consequences and lead to the early onset of osteoporosis. Heterogeneity of POF is also reflected by the variety of possible causes, including autoimmunity, toxics, drugs, as well as genetic defects. POF has a strong genetic component. X chromosome abnormalities (e. g. Turner syndrome) represent the major cause of primary amenorrhea associated with ovarian dysgenesis. Despite the description of several candidate genes, the cause of POF remains undetermined in the vast majority of the cases. Management includes substitution of the hormone defect by estrogen/progestin preparations. The only solution presently available for the fertility defect in women with absent follicular reserve is ovum donation.
引用
收藏
页数:5
相关论文
共 26 条
[11]   Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene [J].
Di Pasquale, E ;
Beck-Peccoz, P ;
Persani, L .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (01) :106-111
[12]   Premature ovarian failure [J].
Goswami, D ;
Conway, GS .
HUMAN REPRODUCTION UPDATE, 2005, 11 (04) :391-410
[13]   Identification of novel mutations in FOXL2 associated with premature ovarian failure [J].
Harris, SE ;
Chand, AL ;
Winship, IM ;
Gersak, K ;
Aittomäki, K ;
Shelling, AN .
MOLECULAR HUMAN REPRODUCTION, 2002, 8 (08) :729-733
[14]   Menstrual disorders in adolescence: investigation and management [J].
Hickey, M ;
Balen, A .
HUMAN REPRODUCTION UPDATE, 2003, 9 (05) :493-504
[15]   Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: Clinical, histological, and molecular studies [J].
Meduri, G ;
Touraine, P ;
Beau, I ;
Lahuna, O ;
Desroches, A ;
Vacher-Lavenu, MC ;
Kuttenn, F ;
Misrahi, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3491-3498
[16]  
Santoro N, 2003, ANN ENDOCRINOL-PARIS, V64, P87
[17]  
Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO
[18]  
2-J
[19]   The bone morphogenetic protein system in mammalian reproduction [J].
Shimasaki, S ;
Moore, RK ;
Otsuka, F ;
Erickson, GF .
ENDOCRINE REVIEWS, 2004, 25 (01) :72-101
[20]  
Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO